CDKN2A and metastatic malignant neoplasm in the lymph nodes: TSGs such as CDKN2A and FAM134B were found to be hypermethylated in CRC patients with lymph node metastasis and in patients with LVI [57,58], highlighting the potential involvement of multiple hypermethylated TSGs in the metastatic cascade and the invasive traits of CRC.